Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
2(50.0%)
4Total
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04102371Phase 3Completed

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Role: collaborator

NCT05462704Phase 3Recruiting

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Role: collaborator

NCT06264700Not ApplicableRecruiting

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

Role: collaborator

NCT03547050Completed

Rolandic Epilepsy Genomewide Association International Study

Role: collaborator

NCT01881490Not ApplicableCompleted

The ImageKids Study: Developing the pMEDIC and the PICMI

Role: collaborator

All 5 trials loaded